Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
The gut microbiome and estrogen receptor-positive female breast cancer
FY 2021-22
Summary
Breast cancer is the most common cancer among Canadian women and the second leading cause of cancer-related death. Even those who survive will face serious negative health impacts, such as the adverse side effects associated with long-term hormone therapy. Therefore, approaches to prevent breast cancer before it starts are critical for improving population health.Estrogen is known to cause HR-positive breast cancer, the most common form of breast cancer. Recent research has shown that specific bacteria in the gut microbiome may control estrogen levels. Through this estrogen regulation, evidence in preclinical studies have suggested the gut microbiome may contribute to breast cancer development, but clinical studies are limited. To better establish the role of the gut microbiome in breast cancer development, we will conduct a study of 70 women newly diagnosed with HR-positive breast cancer and 70 women without cancer. Women will complete questionnaires on lifestyle and diet and provide a stool sample. Whole metagenome sequencing and metabolomics will be performed on stool specimens to determine the type and quantity of bacteria and metabolites present in women with and without breast cancer. We expect that women with breast cancer will have different types of bacteria and higher amounts of estrogen-related bacteria and metabolites. Our results will provide new knowledge on how the gut microbiome may contribute to breast cancer, including mechanisms of action which are important for identifying therapeutic targets. This is an important first step towards identifying potential approaches to change the gut microbiome and prevent breast cancer.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
466509
Name
Larnder Ashley
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The gut microbiome and estrogen receptor-positive female breast cancer
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bacteria; Breast Cancer; Cancer Prevention; Estrogen; Metabolomics; Metagenome Sequencing; Microbiome
Abstract
Breast cancer is the most common cancer among Canadian women and the second leading cause of cancer-related death. Even those who survive will face serious negative health impacts, such as the adverse side effects associated with long-term hormone therapy. Therefore, approaches to prevent breast cancer before it starts are critical for improving population health.Estrogen is known to cause HR-positive breast cancer, the most common form of breast cancer. Recent research has shown that specific bacteria in the gut microbiome may control estrogen levels. Through this estrogen regulation, evidence in preclinical studies have suggested the gut microbiome may contribute to breast cancer development, but clinical studies are limited. To better establish the role of the gut microbiome in breast cancer development, we will conduct a study of 70 women newly diagnosed with HR-positive breast cancer and 70 women without cancer. Women will complete questionnaires on lifestyle and diet and provide a stool sample. Whole metagenome sequencing and metabolomics will be performed on stool specimens to determine the type and quantity of bacteria and metabolites present in women with and without breast cancer. We expect that women with breast cancer will have different types of bacteria and higher amounts of estrogen-related bacteria and metabolites. Our results will provide new knowledge on how the gut microbiome may contribute to breast cancer, including mechanisms of action which are important for identifying therapeutic targets. This is an important first step towards identifying potential approaches to change the gut microbiome and prevent breast cancer.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Larnder, Ashley
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~